Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ImmunityBio (IBRX) Non-Current Deferred Tax Liability: 2015-2022

Historic Non-Current Deferred Tax Liability for ImmunityBio (IBRX) over the last 4 years, with Jun 2022 value amounting to $162,000.

  • ImmunityBio's Non-Current Deferred Tax Liability fell 4.71% to $162,000 in Q2 2022 from the same period last year, while for Jun 2022 it was $162,000, marking a year-over-year decrease of 4.71%. This contributed to the annual value of $162,000 for FY2021, which is 96.65% down from last year.
  • Latest data reveals that ImmunityBio reported Non-Current Deferred Tax Liability of $162,000 as of Q2 2022, which was down 0.00% from $162,000 recorded in Q1 2022.
  • Over the past 5 years, ImmunityBio's Non-Current Deferred Tax Liability peaked at $4.8 million during Q4 2020, and registered a low of $122,000 during Q3 2018.
  • Over the past 3 years, ImmunityBio's median Non-Current Deferred Tax Liability value was $170,000 (recorded in 2021), while the average stood at $833,429.
  • Data for ImmunityBio's Non-Current Deferred Tax Liability shows a maximum YoY plummeted of 96.65% (in 2021) over the last 5 years.
  • Over the past 4 years, ImmunityBio's Non-Current Deferred Tax Liability (Quarterly) stood at $122,000 in 2018, then reached $4.8 million in 2020, then tumbled by 96.65% to $162,000 in 2021, then dropped by 4.71% to $162,000 in 2022.
  • Its Non-Current Deferred Tax Liability stands at $162,000 for Q2 2022, versus $162,000 for Q1 2022 and $162,000 for Q4 2021.